Company Overview - Zhejiang Gongdong Medical Instrument Co., Ltd. specializes in the research, development, production, and sales of disposable medical consumables [1] - The main products include medical testing, blood collection, sampling, medical care, drug packaging, and others [1] Financial Performance - For Q1 2025, the company reported revenue of 264 million yuan, a year-on-year decrease of 2.74% [1] - The net profit for the same period was 27.41 million yuan, down 39.23% year-on-year [1] - The gross profit margin stood at 32.40% [1] Market Position - As of August 22, the company's stock closed at 20.45 yuan, down 1.06%, with a rolling PE ratio of 29.29 times [1] - The total market capitalization is 4.509 billion yuan [1] - In comparison, the average PE ratio for the medical device industry is 56.95 times, with a median of 40.49 times, placing Gongdong Medical at the 58th position in the industry ranking [1][2] Shareholder Information - As of March 31, 2025, the number of shareholders increased to 8,909, up by 735 from the previous count [1] - The average market value of shares held by each shareholder is 352,800 yuan, with an average holding of 27,600 shares [1]

Company Overview - Company name: Zhejiang Gongdong Medical Technology Co., Ltd. specializes in the research, production, and sales of disposable medical consumables [1] - Main products include medical testing, blood collection, sampling, medical care, drug packaging, and others [1] Financial Performance - For Q1 2025, the company reported revenue of 264 million yuan, a year-on-year decrease of 2.74% [1] - Net profit for the same period was 27.41 million yuan, down 39.23% year-on-year [1] - The sales gross margin stood at 32.40% [1] Market Position - The company's current stock price is 20.23 yuan, with a PE ratio of 28.98 times [1] - The total market capitalization is 4.461 billion yuan [1] - In comparison to the medical device industry, which has an average PE ratio of 55.76 times and a median of 39.14 times, the company ranks 57th [1][2] Shareholder Information - As of March 31, 2025, the number of shareholders is 8,909, an increase of 735 from the previous count [1] - The average market value held by each shareholder is 352,800 yuan, with an average holding of 27,600 shares [1]

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Gongdong Medical, which closed at 20.96 yuan, up 3.76%, with a rolling PE ratio of 30.02, marking a new low in 33 days, and a total market capitalization of 4.622 billion yuan [1][2] - Gongdong Medical's PE ratio is significantly lower than the industry average of 55.70 and the industry median of 39.08, ranking 58th in the medical device sector [1][2] - As of March 31, 2025, Gongdong Medical had 8,909 shareholders, an increase of 735 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Gongdong Medical specializes in the research, production, and sales of disposable medical consumables, with key products including medical testing, blood collection, collection, medical care, and drug packaging [1] - The latest quarterly report for Q1 2025 shows Gongdong Medical achieved revenue of 264 million yuan, a year-on-year decrease of 2.74%, and a net profit of 27.41 million yuan, down 39.23%, with a gross profit margin of 32.40% [1]

Company Overview - Company name: Zhejiang Gongdong Medical Instrument Co., Ltd. specializes in the research, production, and sales of disposable medical consumables [1] - Main products include medical testing, blood collection, sampling, medical care, drug packaging, and others [1] Financial Performance - As of Q1 2025, the company reported revenue of 264 million yuan, a year-on-year decrease of 2.74% [1] - Net profit for the same period was 27.41 million yuan, down 39.23% year-on-year [1] - The sales gross margin stood at 32.40% [1] Market Position - The company's current stock price is 19.83 yuan, with a PE ratio of 28.40 times [1] - Total market capitalization is 4.372 billion yuan [1] - Compared to the industry average PE of 54.56 times and median PE of 37.54 times, the company ranks 56th in the medical device sector [1][2] Shareholder Information - As of March 31, 2025, the number of shareholders increased to 8,909, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1]

Company Overview - Company name: Zhejiang Gongdong Medical Instrument Co., Ltd. specializes in the research, production, and sales of disposable medical consumables [1] - Main products include medical testing, blood collection, sampling, medical care, drug packaging, and others [1] Financial Performance - As of Q1 2025, the company reported revenue of 264 million yuan, a year-on-year decrease of 2.74% [1] - Net profit for the same period was 27.41 million yuan, down 39.23% year-on-year [1] - The sales gross margin stood at 32.40% [1] Market Position - The company's closing stock price on July 4 was 20.72 yuan, with a PE ratio of 29.68 times [1] - The total market capitalization is 4.569 billion yuan [1] - In comparison, the average PE ratio for the medical device industry is 51.05 times, with a median of 36.62 times, placing Gongdong Medical at the 66th position in the industry [1][2] Institutional Holdings - As of Q1 2025, four institutions hold shares in Gongdong Medical, including two funds, with a total holding of 14.5259 million shares valued at 402 million yuan [1]

Company Overview - Company name: Zhejiang Gongdong Medical Instrument Co., Ltd. specializes in the research, production, and sales of disposable medical consumables [1] - Main products include medical testing, blood collection, sampling, medical care, drug packaging, and others [1] Financial Performance - As of Q1 2025, the company reported revenue of 264 million yuan, a year-on-year decrease of 2.74% [1] - Net profit for the same period was 27.41 million yuan, down 39.23% year-on-year [1] - The sales gross margin stood at 32.40% [1] Market Position - The company's stock closed at 26.69 yuan, with a PE ratio of 27.32, marking a new low in 24 days [1] - The total market capitalization is 4.206 billion yuan [1] - In comparison, the average PE ratio for the medical device industry is 49.84, with a median of 36.59, placing Gongdong Medical at 61st in the industry ranking [1][2] Institutional Holdings - As of Q1 2025, four institutions hold shares in Gongdong Medical, including two funds, with a total holding of 14.5259 million shares valued at 402 million yuan [1]

Company Overview - Zhejiang Gongdong Medical Instrument Co., Ltd. specializes in the research, production, and sales of disposable medical consumables [1] - The main products include medical testing, blood collection, sampling, medical care, drug packaging, and others [1] Financial Performance - For Q1 2025, the company reported revenue of 264 million yuan, a year-on-year decrease of 2.74% [1] - The net profit for the same period was 27.41 million yuan, reflecting a year-on-year decline of 39.23% [1] - The sales gross margin stood at 32.40% [1] Market Position - As of May 6, the company's stock closed at 24.18 yuan, with a rise of 2.76% [1] - The rolling price-to-earnings (PE) ratio is 24.75, while the industry average PE is 48.90 [1][2] - The total market capitalization of the company is 3.81 billion yuan [1] Institutional Holdings - As of Q1 2025, four institutions hold shares in Gongdong Medical, with a total of 14.52 million shares valued at 402 million yuan [1]

最新一期业绩显示，2024年年报，公司实现营业收入11.15亿元，同比14.37%；净利润1.72亿元，同比 57.28%，销售毛利率32.79%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)55拱东医疗23.1723.172.3339.77亿行业平均 47.5750.854.63102.62亿行业中值30.2831.072.3546.21亿1天益医疗-2765.27-2765.271.7320.57亿2硕世生 物-1906.47-1906.471.1738.16亿3诺唯赞-513.28-513.282.3592.87亿4澳华内镜-510.10255.844.0953.76亿5博 晖创新-347.54-213.983.8353.34亿6康泰医学-263.6230.932.6951.27亿7华大基因-198.58217.222.05201.80亿 8奥精医疗-119.70-119.701.5321.69亿9睿昂基因-72.42-72.421.2611.42亿10热景生物-71.15-71.153.91127.52 亿11中红医疗-66.05-52.690.8445.90亿 来源：金融界 股东方面，截 ...